rss mail face

Publicaciones 2014

1. Flores V, Rodríguez-Sánchez B, Marín-Jiménez I, Bouza E, Menchén L, Muñoz P.
Prospective study of BK virus infection in patients with inflammatory bowel disease.
Sci World J. 2014;2014:970528. doi: 10.1155/2014/970528


2. Martín-Gandul C, Pérez-Romero P, González-Roncero FM, Berdaguer S, Gómez MA, Lage E, Sánchez M, Cisneros JM, Cordero E.
Spanish Network for Research in Infectious Diseases REIPI. Clinical impact of neutropenia related with the preemptive therapy of CMV infection in solid organ transplant recipients.
J Infect. 2014;69:500-6


3. Meije Y, Fortún J, Len Ó, Aguado JM, Moreno A, Cisneros JM, Gurguí M, Carratalà J, Muñoz P, Montejo M, Blanes M, Bou G, Pérez JL, Torre-Cisneros J, Ramos A, Pahissa A, Gavaldà J.
Spanish Network for Research on Infection in Transplantation (RESITRA) and the Spanish Network for Research on Infectious Diseases (REIPI). Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort
Transpl Infect Dis. 2014;16:387-96


 

 
Publicaciones 2013

1. Bárcena R, Moreno A, Rodríguez-Gandía MA, Albillos A, Arocena C, Blesa C, et al.
Hospital Ramón y Cajal Liver Transplant Group Safety andanti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.
J Hepatol. 2013 Mar;58(3):421-6


2. Bartoletti M, Cervera C, Hoyo I, Linares L, Sanclemente G, Bosch J, Marco F, Cofán F, Ricart MJ, Navasa M, Moreno A.
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation.
Mycoses. 2013 Mar;56(2):162-167


3. Berastegui C, Monforte V, Bravo C, Sole J, Gavalda J, Tenório L, Villar A, Rochera MI, Canela M, Morell F, Roman A.
[Lung transplantation in pulmonary fibrosis and other interstitial lung diseases.]
Med Clin (Barc). 2013 Sep 9. [Epub ahead of print]


4. Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, Cruzado JM, Carratalà J.
Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
TRANSPLANTATION 2013; 96: 843-9.


5. Cantisan S, Lara R, Montejo M, et al.
Pretrasplant Interferon-? Secretion by CMV-Specific CD8+TCells Inform the Risk of CMV Replication After Trasplantation.
Am J Trasplant 2013;13:738-745.


6. Cantisán S, Torre-Cisneros J, Lara R, Zarraga S, Montejo M, Solana R.
Impact of Cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation.
J Gerontol A Biol Sci Med Sci. 2013; 68(1): 1-5.


7. Clari MA, Bravo D, Costa E, Muñoz-Cobo B, Solano C, Remigia MJ, Giménez E, BenMarzouk-Hidalgo OJ, Pérez-Romero P, Navarro D.
Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.
Diagnostic Microbiology and Infectious Disease. 2013 Feb;75(2):207-9.


8. Coll, E; Torre-Cisneros, J; Calvo, R; Garrido, G; Matesanz, R.
Incidence of Tuberculosis in Deceased-Organ Donors and Transmission Risk to Recipients in Spain.
Transplantation. 2013 Jul 27; 96(2):205-10


9. Cordero E; de la Torre-Cisneros J; Moreno A; Pérez-Romero P; Riera M.
The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients.
Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:38-42


10. Cuervo G, Garcia-Vidal C, Nucci M, Puchades F, Fernández-Ruiz M, Mykietiuk A, Manzur A, Gudiol C, Peman J, Viasus D, Ayats J, Carratalà J.
Effect of statin use on outcomes of adults with candidemia.
PLoS ONE 2013; 8 :e77317.


11. Falantes JF, Calderón C, Márquez-Malaver FJ, Aguilar-Guisado M, Martín-Peña A, Martino ML, Montero I, González J, Parody R, Pérez-Simón JA, Espigado I.
Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. Candidates for primary antifungal prophylaxis.
Clinical Lymphoma, Myeloma & Leucemia, in press 2013.


12. Constantino Fernández-Rivera, Cristina Varela, E. Sabater-Cabrera, Elena Ruiz-Beato, Julián Torre-Cisneros, Luis Guirado Perich.
Análisis coste-utilidad de valganciclovir durante 200 días frente a 100 días post-trasplante como tratamiento preventivo de la enfermedad por citomegalovirus en receptores de trasplante renal de alto riesgo.
Pharmacoeconomics SRA. 2013; 10, (Issue 1); 15-25.


13. Fernandez-Ruiz M, Lopez-Medrano F, Andres A, et al.
Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients.
Transpl Infect Dis 2013 Dec;15(6):600-11.


14. Fernandez-Ruiz M, Lopez-Medrano F, Varela-Pena P, et al.
Hypocomplementemia in kidney transplant recipients: impact on the risk of infectious complications.
Am J Transplant 2013 Mar;13(3):685-94.


15. Fernandez-Ruiz M, San-Juan R, Aguado JM.
Epstein-Barr virus DNAemia and infectious complications after preemptive rituximab treatment.
Transplantation 2013 Feb 15;95(3):e13.


16. Garcia-Reyne A, Lumbreras C, Fernandez I, et al.
Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
Transpl Infect Dis 2013 Aug;15(4):405-15.


17. Garcia-Vidal C, Viasus D, Carratalà J.
Pathogenesis of invasive fungal infections.
Current Opinion Infect Dis 2013; 26: 270-6 I


18. Gayoso I, Cantisán S, Cerrato S, Sánchez-García j, Martín C, Solana R, Torres-Gómez A, Torre-Cisneros J.
Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation.
Clin Dev Immunol. 2013; 2013:347213.


19. Gavaldà J, Cabral E, Pérez-Romero P, Len O, Aydillo T, Campins M, Quintero J, Peghin M, Nieto J, Charco R, Pahissa A, Cordero E;
Spanish Network for the Research in Infectious Diseases (REIPI). Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.
Pediatr Transplant. 2013 Jun;17(4):403-6.


20. González-Padilla M, Castón JJ, Vidal E, Arizón JM, Segura C, Montejo M, Rivero A, Torre-Cisneros J.
Epidemiology and clinical impact of infection in patients awaiting heart transplantation.
Int J Infect Dis. 2013 Sep;17(9):e681-5.


21. Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T.
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?.
Int J Cardiol. 2014; 171:15-23


22. Gracia-Ahufinger I; Gutiérrez-Aroca J; Cordero E; Vidal E; Cantisán S; del Castillo D; Martín-Gandul C; Rivero A; Torre-Cisneros J.
Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.
Transplantation. 2013 Apr 27;95(8):1015-20.


23. Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, Domingo-Domenech E, Jiménez L, Carratalà J.
Changing etiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Clin Microbiol Infect 2013; 19: 474-9.


24. Gudiol C, Camoez M, Domínguez MA, Garcia-Vidal C, Bodro M, Ardanuy C, Obed M, Arnan M, Antonio M, Carratalà J.
Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.
PLoS ONE 2013; 8: e74734.


25. Herrero-Martinez JM, Lumbreras C, Manrique A, et al.
Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation.
Clin Microbiol Infect 2013 Dec;19(12):1132-9.


26. Jaramillo N, Segovia J, Gómez-Bueno M, García-Cosío D, Castedo E, Serrano S, Burgos R, García Montero C, Ugarte J, Martínez Cabeza P, Alonso-Pulpón L.
Characteristics of Patients With Survival Longer Than 20 Years Following Heart Transplantation.
Rev Esp Cardiol. 2013; 66:797-802


27. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L.
Humar A Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.; Transplantation Society International CMV Consensus Group.
Transplantation. 2013 Aug 27;96(4):333-60.


28. Ledesma J, Bouza E, González-Nicolás MA, de Viedma DG, Rodríguez-Sánchez B, Muñoz P.
BK polyomavirus genotyping at inter- and intra-patient level in Spain.
J Med Virol. 2013 Aug;85(8):1402-8.


29. López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MA, Pérez-Romero P, Sabé N, Gómez-Bravo MA, Delgado JF, Cabral E, Carratalá J.
Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI). Executive summary. Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).
Enferm Infecc Microbiol Clin. 2013 Oct;31(8):528-34.


30. López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MA, Pérez-Romero P, Sabé N, Gómez-Bravo MA, Delgado JF, Cabral E, Carratalá J.
Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI). Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).
Enferm Infecc Microbiol Clin. 2013 Oct;31(8):526.e1-526.e20.


31. Martín-Gandul C*, Pérez-Romero P*, Sánchez M, Bernal G, Suárez G, Sobrino M, Merino L, Cisneros JM, Cordero E.
The Spanish Network for Research in Infectious Diseases (REIPI). Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.
J Clin Virol. 2013 Jan;56(1):13-18. *Both author contributed equally to this work.


32. Martín-Peña A, Aguilar-Guisado M, Cisneros JM.
Does the current treatment of invasive fungal infection need to be reviewed?.
Enfermedades Infecciosas y Microbiología Clínica, 2013 (en prensa).


33. Martín-Peña A, Gil-Navarro MV, Aguilar-Guisado M, Espigado I, de Pipaón MR, Falantes J, Pachón J, Cisneros JM.
Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.
Antimicrob Agents Chemother. 2013;57(10):4664-72.


34. Monforte V, López-Sánchez A, Zurbano F, Ussetti P, Solé A, Casals C, Cifrian J, de Pablos A, Bravo C, Román A.
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant.
J Heart Lung Transplant. 2013 Mar;32(3):313-9


35. Munoz P, Valerio M, Palomo J, et al.
Targeted antifungal prophylaxis in heart transplant recipients.
Transplantation 2013 Oct 15;96(7):664-9.


36. Muñoz P, Cerón I, Valerio M, Palomo J, Villa A, Eworo A, Fernández-Yáñez J, Guinea J, Bouza E.
Invasive Aspergillosis Among Heart Transplant Recipients: A 24-Year Perspective II.
Journal of Heart and Lung trasplantation (in press).


37. San-Juan R, De Dios B, Garcia-Reyne A, et al.
Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant.
J Clin Virol 2013 Apr;56(4):316-22.


38. San-Juan R, De Dios B, Navarro D, et al.
Epstein-Barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients.
Transplantation 2013 Mar 15;95(5):688-93.


39. Sousa D, Justo I, Domínguez A, Manzur A, Izquierdo C, Ruiz L, Nebot M, Bayas JM, Celorrio JM, Varona W, Llinares P, Miguez E, Sánchez E, Carratalà J.
Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome.
Clin Microbiol Infect 2013; 19: 187-92


40. Sun, Hsin-Yun; Munoz, Patricia; Torre-Cisneros, Julian; Aguado, Jose M.; Lattes, Roberta; Montejo, Miguel; Garcia-Reyne, Ana; Bouza Emilio; Valerio, Maricela; Lara, Rosario; John, George T.; Bruno, Didier; Singh, Nina.
Mycobacterium Tuberculosis—Associated Immune Reconstitution Syndrome in Solid-Organ Transplant Recipient.
Trasplantation 2013;95 (9) : 1173-81.


41. Zuckermann A, Wang SS, Epailly E, Barten MJ, Sigurdardottir V, Segovia J, Varnous S, Turazza FM, Potena L, Lehmkuhl HB.
Everolimus immunosuppression in de novo heart transplant recipients: what does the evidence tell us now?.
Transplant Rev (Orlando). 2013; 27:76-84.

 
Publicaciones 2012

Aguado JM, Navarro D, San Juan R, Castón JJ.
Cytomegalovirus infection in solid organ transplantation.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2012; 30 (Suppl 2): 57-62.


Aguado JM, Varo E, Usetti P, Pozo JC, Moreno A, Catalán M, Len O, Blanes M, Solé A, Muñoz P, Montejo M, TOSCANA Study Group.
Safety of anidulafungin in solid organ transplant recipients.
LIVER TRANSPLANTATION 2012; 18: 680- 685.


Berdaguer S, Bautista J, Brunet M, Cisneros JM.
Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2012; 30 (Suppl 2): 86-92.


Bodro M, Sabé N, Gomila A, Ayats J, Baliellas C, Roca J, Melilli E, Carratalà J.
Risk factors, clinical characteristics and outcomes of invasive fungal infection in solid organ transplant recipients.
TRANSPLANTATION PROCEEDINGS 2012; 44: 2682-2685.


Bodro M, Sabé N, Lladó L, Baliellas C, Niubó J, Castellote J, Fabregat J, Rafecas A, Carratalà J.
Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.
LIVER TRANSPLANTATION 2012; 18: 1093-1099.


Bodro M, Sabé N, Santín M, Cruzado JM, Llado L, González-Costello J, Carratalà J.
Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
TRANSPLANTATION PROCEEDINGS 2012; 44: 2686-2689.


Brennan DC, Aguado JM, Potena L, Jardine AG, Legendre C, Säemann MD, Mueller NJ, Merville P, Emery V, Nashan B.
Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.
REV MEDICAL VIROLOGY 2012.


Cantisán S, Martín C, Romero-Sánchez MC, Ferrando-Martínez S, Martínez F, Rivero A, Torres A, Solana R, Torre-Cisneros J.
Role of defective thymic function in onset of ganciclovir-resistant cytomegalovirus after cord blood transplantation.
CLINICAL VACCINE IMMUNOLOGY 2012; 19:1994-1998.


Cantisan S, Torre-Cisneros J, Lara R, Zarraga S, Montejo M, Solana R.
Impact of Cytomegalovirus on Early Immunosenescence of CD8+ T Lymphocytes After Solid Organ Transplantation.
J GERONTOL A BIOL SCI MED SCI 2012 ;68:1-5.


Carratalà J, Len O, de la Torre-Cisneros J.
Daptomicina en las infecciones por bacterias grampositivas en los pacientes oncohematológicos y receptores de trasplante.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2012; 30 (Supl 1): 43-49.


Carratalà J, Montejo M, Pérez P.
Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2012; 30 (Suppl 2): 63-69.


Casquero S, Rangel D, Lage E, Sobrino M, Cristobo P, Cordero E, Cisneros JM.
Preemptive therapy in the prevention of CMV disease in high and low risk heart transplant patients.
TRANSPLANTATION PROCEDINGS 2012; 44:2113-2114.


Cervera C.
Candidemia and invasive candidiasis in the adult: clinical forms and treatment.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30: 483-491.


Cervera C, Linares L, Bou G, Moreno A.
Multidrug-resistant bacterial infection in solid organ transplant recipients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2012; 30 (Supl 2): 40-48.


Clari MA, Bravo D, Costa E, Muñoz-Cobo B, Solano C, Remigia MJ, Giménez E, Benmarzouk-Hidalgo OJ, Pérez-Romero P, Navarro D.
Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES 2012 Nov 20.


Cordero E, Aydillo T, Fariñas MC, Paño-Pardo JR, Pachón J, Viasus D, Riera M, López-Medrano F, Payeras A, Moreno A, Rodríguez-Baño J, Oteo JA, Martínez- Montauti J, Torre-Cisneros J, Segura F, Carratalà J.
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES 2012; 31: 547- 556.


Cordero E, Aydillo TA, Perez-Ordoñez A, Torre-Cisneros J, Lara R, Segura C, Gentil MA, Gomez-Bravo MA, Lage E, Pachon J, Perez-Romero P.
Deficient Long- Term Response to Pandemic Vaccine Results in An Insufficient Antibody Response to Seasonal Influenza Vaccination in Solid Organ Transplant Recipients.
TRANSPLANTATION 2012; 93: 847-854.


Cordero E, de la Torre-Cisneros J, Moreno A, Pérez-Romero P, Riera M.
The impact of influenza A (H1N1) pdm09 infection on immunosuppressed patients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2012; 30 (Suppl 4):38-42.


Cordero E, de la Torre-Cisneros J, Moreno A, Pérez-Romero P, Riera M.
The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Suppl 4): 38-42.


Cordero E, Folgueira MD, Marcos MA, López-Medrano F.
Other viral infections in solid organ transplantation.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Suppl 2): 70-75.


Cordero E, Manuel O.
Influenza vaccination in solid-organ transplant recipients.
CURRENT OPINION IN ORGAN TRANSPLANTATION. 2012 ; 17: 601-608.


Cordero E, Pérez-Romero P, Moreno A, Len O, Montejo M, Vidal E, Martín-Dávila P, Fariñas MC, Fernández-Sabé N, Giannella M, Pachón J, and the Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases.
Pandemic influenza A (H1N1) virus infection in solid organ transplant recipients: impact of the viral and non-viral co-infection.
CLINICAL MICROBIOLOGY AND INFECTION 2012; 18: 67-73.


Doblas A, Alcaide F, Benito N, Gurguí M, Torre-Cisneros J.
Tuberculosis in solid organ transplant patients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Suppl 2): 34-39.


Fernández-Ruiz M, López-Medrano F, Varela-Peña P, Lora-Pablos D, García-Reyne A, González E, Morales JM, San Juan R, Lumbreras C, Paz-Artal E, Andrés A, Aguado JM.
Monitoring of Immunoglobulin Levels Identifies Kidney Transplant Recipients at High Risk of Infection.
AMERICAN JOURNAL OF TRANSPLANTATION 2012; 12: 2763-73.


Fernández-Ruiz M, Silva JT, San Juan R, de Dios B, García-Luján R, López- Medrano F, Lizasoain M, Aguado JM.
Aspergillus tracheobronchitis. Report of 8 cases and review of the literatura.
MEDICINE (Baltimore) 2012; 91: 261-73.


Fernández-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, Torre- Cisneros J, Martín-Dávila P, Noblejas A, Len O, Garcia-Reyne A, del Pozo JL, Carratalà J.
Risk factors, clinical features, and outcomes of toxoplasmosis in solid organ transplant recipients. A matched case-control study.
CLINICAL INFECTIOUS DISEASES 2012; 54: 355-361.


Fortún J, Meije Y, Fresco G, Moreno S.
Aspergillosis. Clinical forms and treatment.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012 Apr;30(4):201-8.


Fortún J, Ruiz I, Martín-Dávila P, Cuenca-Estrella M.
Fungal infection in solid organ recipients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Suppl 2): 49-56.


Garcia-Vidal C, Carratalà J.
Patogenia de la infección fúngica invasora.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30: 151-158.


Garcia-Vidal C, Ardanuy C, Gudiol C, Cuervo G, Calatayud L, Bodro M, Duarte R, Fernández-Sevilla A, Antonio M, Liñares J, Carratalà J.
Bacteremia caused by Streptococcus pneumoniae in cancer patients: clinical features, serotypes, genotypes and outcomes.
JOURNAL OF INFECTION 2012; 65: 521-527.


Gastaca M, Agüero F, Rimola A, Montejo M, Miralles P, Lozano R, Castells L, Abradelo M, de la Mata M, San Juan F, Cordero E, del Campo S, Manzardo C, de Urbina JO, Perez I, de la Rosa G, Miro JM, The FIPSE OLT-HIV Investigators.
Liver retransplantation in HIV-infected patients: a prospective cohort study.
AMERICAN JOURNAL OF TRANSPLANTATION 2012; 12: 2465-2476.


Gastaca M, Matarranz A, Muñoz F, Valdivieso A, Aguinaga A, Testillano M, Bustamante J, Terreros I, Suarez MJ, M. Montejo, Ortiz de Urbina J.
Biliary Complications in Orthotopic Liver Transplantation Usin Choledochocholedochostomy with a T-tube.
TRANSPLANTATION PROCEEDINGS 2012; 44:1554-1556.


Gastaca M, Valdivieso A, M. Montejo, Bustamante J, de Urbina JO.
Is Antithrombotic Prophylaxis Required After Liver Transplantation in HIV-Infected Recipients?
AMERICAN JOURNAL OF TRANSPLANTATION 2012;12:2258.


Gavaldà J, Cabral E, Alonso E, Perez-Romero P, Pérez A, Quintero J, Campins M, Vilalta R, Alonso A, Len O, Navarro M, Nieto J, Jara P, Charco R, Pahissa A, Cordero E.
Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients.
TRANSPLANT INFECTIOUS DISEASES 2012;14:584-588.


Gavaldà J, Meije Y, Len O, Pahissa A.
Invasive fungal infection in solid organ transplant.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2012; 30:645-653.


Gavaldà J, Vidal E, Lumbreras C.
Infection prevention in solid organ transplantation.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Suppl) 2: 27-33.


Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, Domingo- Domenech E, Jiménez L, Carratalà J.
Changing etiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
CLINICAL MICROBIOLOGY AND INFECTION 2012 Mar 31.


Hoyo I, Sanclemente G, Cervera C, Cofán F, Ricart MJ, Perez-Villa F, Navasa M, Marcos MA, Puig de la Bellacasa J, Moreno A.
Opportunistic pulmonary infections in solid organ transplant recipients.
TRANSPLANTATION PROCEEDINGS 2012; 44(9: 2673-2675.


Len O, Rodriguez-Pardo D, Gavaldà J, Aguado JM, Blanes M, Borrell N, Bou G, Carratalà J, Cisneros JM, Fortún J, Gurguí M, Montejo M, Cervera C, Muñoz P, Asensio A, Torre-Cisneros J, Pahissa A on behalf of RESITRA/REIPI.
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicenter cohort study.
TRANSPLANT INTERNATIONAL 2012; 25: 1275-1281.


López-Cortes LE, Garcia-Vidal C, Ayats J, Gudiol C, Bodro M, Sánchez-Ortega I, Peña C, Carratalà J.
Aspergilosis invasora con afectación extrapulmonar: patogenia, características clínicas y pronóstico.
REVISTA IBEROAMERICANA DE MICOLOGÍA 2102; 29: 139-143.


López-Medrano F, Carratalà J, Cruzado JM, Gutiérrez MJ, Aguado JM.
Fever in a kidney transplant recipient: no facts and many interactions.
REVISTA CLÍNICA ESPAÑOLA 2012; 212: 193-197.


López-Medrano F, Fariñas MC, Payeras A, Pachón J.
Antiviral treatment and vaccination for influenza A (H1N1)pdm09 virus: lessons learned from the pandemic.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Suppl 4): 49-53.


Martín-Gandul C, Pérez-Romero P, Sánchez M, Bernal G, Suárez G, Sobrino M, Merino L, Cisneros JM, Cordero E.
The Spanish Network for Research in Infectious Diseases (REIPI). Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.
JOURNAL OF CLINICAL VIROLOGY 2012 Nov 3.


Miró JM, Blanes M, Norman F, Martín-Dávila P.
Infections in solid organ transplantation in special situations: HIV-infection and immigration.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012: 30 (Suppl 2): 76-85.


Miro JM, Cofan F, Trullas JC, Manzardo C, Cervera C, Tuset M, Oppenheimer F, Brunet M, Moreno A, Campistol JM, Gatell JM.
Renal Dysfunction in the Setting of HIV/AIDS.
CURRENT HIV/AIDS REP 2012; 9:187-199.


Miró JM, Montejo M, Castells L, Rafecas A, Moreno S, Agüero F, Abradelo M, Miralles P, Torre-Cisneros J, Pedreita JD, Coredro E, de la Rosa G, Moyano B, Moreno A, Pérez I, Rimola A, and the Spanish OLT in HIV-infected patients working group investigators.
Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.
AMERICAN JOURNAL OF TRANSPLANTATION 2012; 12: 1866-1876.


Morales JM, Aguado JM.
Hepatitis C and renal transplantation.
CURRENT OPINION IN ORGAN TRANSPLANTATION 2012; 17: 609-615.


Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, Leno O, Rafecas A, Martín-Dávila P, Torre-Cisneros J, Salcedo M, Cordero E, Lázaro R, Pérez I, Rimola A, Miró JM, and the OLT-HIV FIPSE Cohort Investigators.
Epidemiology and outcome of infections in HIV-HCV-coinfected liver transplant recipients: A FIPSE/GESIDA prospective cohort study.
LIVER TRANSPLANTATION 2012; 18: 70-81.


Muñoz P, Fernández NS, Fariñas MC.
Epidemiology and risk factors of infections after solid organ transplantation.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Suppl 2): 10-8.


Muñoz P, Rojas L, Cervera C, Garrido G, Fariñas MC, Valerio M, Giannella M, Bouza E, and COMIT Study Group.
Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety.
CLINICAL TRANSPLANTATION 2012; 26: 87-96.


Pahissa A, Moreno A, Pérez JL (editores).
Infections in Solid Organ Transplantation.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2012; 30 (Extraordinario 2).


Pérez-Romero P, Aydillo TA, Pérez-Ordoñez A, Muñoz P, Moreno MA, López- Medrano F, Bodro M, Montejo M, Gavaldà J, Fariñas MC, Pachón J, Cordero E and the Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases.
Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease.
CLINICAL MICROBIOLOGY AND INFECTION 2012; 18: E533-E540.


Ruiz-Cano MJ, Fernández-Ruiz M, Sánchez V, López-Medrano F.
Constrictive pericarditis due to Candida albicans: An unexpected cause of pericardial effusion after heart transplantation.
REVISTA CLÍNICA ESPAÑOLA 2012; 212: 551-552.


Sabé N, González-Costello J, Rama I, Niubó J, Bodro M, Roca J, Cruzado JM, Manito N, Carratalà J.
Succesful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors.
TRANSPLANT INTERNATIONAL 2012; 25: e78-e82.


San-Juan R, De Dios B, Navarro D, García-Reyne A, Lumbreras C, Bravo D, Costa E, Morales JM, Andres A, Jiménez-Romero C, Delgado J, Fernández-Ruiz M, López-Medrano F, Aguado JM.
Epstein-Barr Virus DNAemia Is an Early Surrogate Marker of the Net State of Immunosuppresion in Solid Organ Transplant Recipients.
TRANSPLANTATION 2012 (Epub ahead of Print).


Sousa D, Justo I, Domínguez A, Manzur A, Izquierdo C, Ruiz L, Nebot M, Bayas JM, Celorrio JM, Varona W, Llinares P, Miguez E, Sánchez E, Carratalà J.
Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome.
CLINICAL MICROBIOLOGY AND INFECTION 2012 Jan 10.


Torre Cisneros J, Arias-Rodríguez M, Aguado JM, Campistol JM.
Presente y futuro de la infección por citomegalovirus en el trasplante renal.
NEFROLOGÍA Sup Ext 2012; 3: 1-3.


Valdivieso A, Ventoso A, Gastaca M, Bustamante J, Aguinaga A, Ruiz P, Gonzalez-Uriarte J, Martínez-Indart L, Testillano M, Fernández JR, Muñoz F, M. Montejo, Matarranz A, Suárez MJ, Ortiz de Urbina J.
Does the transjugular intrahepaticportosystemic influence the outcome of liver transplantation?
TRANSPLANTATION PROCEEDINGS 2012;44:1505-1507.


Vidal E, Torre-Cisneros J, Blanes M, Montejo M, Cervera C, Aguado JM, Len O, Carratalà J, Cordero E, Bou G, Muñoz P, Ramos A, Gurguí M, Borrell N, Fortún J.
Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort.
TRANSPLANT INFECTIOUS DISEASE 2012; 14: 595-603.

 
Publicaciones 2011

Aguado JM, Gil-Vernet S.
Profilaxis de la infección por citomegalovirus en el trasplante renal.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 38-41.


Aguilar-Guisado M, Jiménez-Jambrina M, Espigado I, Rovira M, Martino R, Oriol A, Borrell N, Ruiz I, Martín-Dávila P, de la Cámara R, Salavert M, de la Torre J, Cisneros JM; Spanish Network for Research in Infectious Diseases.
Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study.
CLINICAL TRANSPLANTATION 2011; 25: e629-38.


Arnan M, Gudiol C, Calatayud L, Liñares J, Domínguez MA, Batlle M, Ribera JM, Carratalà J, Gudiol F.
Risk factors for, and clinical relevance of, faecal extended-spectrum Beta-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with hematological malignancies.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES 2011; 30: 355-360.


Ayats J, Martín-Mazuelos E, Pemán J, Quindós G, Sánchez F, García-Rodríguez J, Guarro J, Guinea J, Linares MJ, Pontón J, Rodríguez-Tudela JL, Cuenca-Estrella M, Grupo de Estudio de Micología Médica de la SEIMC.
Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29: 39.e1-e15.


Barberan J, Mensa J, Vallejo C, Jarque I, García Ruiz JC, et al (Aguado JM, Fortún J, Montejo M, de la Torre-Cisneros J).
Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient.
REVISTA ESPAÑOLA DE QUIMIOTERAPIA 2011; 24: 263-70.


Barret JP, Gavaldà J, Bueno J, Nuvials X, Pont T, Masnou N, Colomina MJ, Serracanta J, Arno A, Huguet P, Collado JM, Salamero P, Moreno C, Deulofeu R, Martínez-Ibáñez V.
Full face transplant: the first case report.
ANNALS SURGERY 2011; 254: 252-6.


Benmarzouk-Hidalgo OJ, Cisneros JM, Cordero E, Martín-Peña A, Sanchez B, Martin-Gandul C, Gentil MA, Gomez-Bravo MA, Lage E, Perez-Romero P.
Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment.
TRANSPLANTATION 2011; 91: 927-33.


Benmarzouk-Hidalgo OJ, Cordero E (CO1º), Gómez-Cías T, Sánchez M, González-Padilla JD, Infante-Cossio P, Sicilia-Castro D, Hernández-Guisado JM, Pérez-Romero P.
First Face Composite Tissue Transplant Successfully Treated for CMV Infection with Pre-Emptive Valganciclovir Treatment.
ANTIMICROBIAL AGENTS CHEMOTHERAPY 2011;55: 5949-51.


Benmarzouk-Hidalgo O, Molina J, Cordero E, Merino L, Cabello V, Suarez-Artacho G, Sobrino M, Perez-Romero P.
Asymptomatic and symptomatic respiratory virus nfection detected in nasopharyngeal swabs form solid organ transplant recipients early after transplantation.
JOURNAL OF CLINICAL VIROLOGY 2011; 252: 276-277.


Bouza E, Burillo A, Guembe M.
Managing intravascular catheter-related infections in heart transplant patients: how far can we apply IDSA guidelines for immunocompromised patients?
CURRENT OPINION INFECTIOUS DISEASES 2011; 24: 302-8.


Cantisán S, Navarro D.
Estrategias de monitorización inmunológica para la infección por citomegalovirus. Tratamientos de base inmunológica.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 28-32.


Castón JJ, Goñi FZ.
Efectos indirectos de la infección por citomegalovirus.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 6-10.


Castón JJ, Linares MJ, Rivero A, Casal M, Torre-Cisneros J.
Clinical differences between invasive pulmonary infection due to scedosporium apiospermum and invasive pulmonary aspergillosis.
MYCOSES 2011; 54: e468-73.


Cervera C, Fernández-Avilés F, de la Calle-Martin O, Bosch X, Rovira M, Plana M, Moreno A, García F, Miró JM, Martínez A, Gallart T, Carreras E, Blade J, Gatell JM.
Nonmyeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia.
EUROPEAN JOURNAL OF HAEMATOLOGY 2011 ; 87: 87-91.


Cervera C, Fernández-Ruiz M, Valledor A, Linares L, Antón A, Angeles Marcos M, Sanclemente G, Hoyo I, Cofán F, Ricart MJ, Pérez-Villa F, Navasa M, Pumarola T, Moreno A.
Epidemiology and risk factors for late infection in solid organ transplant recipients.
TRANSPLANT INFECTIOUS DISEASE 2011; 13:598-607.


Cervera C, Gurguí M, Lumbreras C.
Factores de riesgo de enfermedad por citomegalovirus en el receptor de un trasplante de órgano sólido.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 11-17.


Cisneros JM, Varo E.
Profilaxis de la infección por citomegalovirus en el trasplante hepático.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 42-45.


Cordero E, Len O.
Esquemas de prevención de la infección por citomegalovirus: terapia anticipada frente a profilaxis universal.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 33-37.


Cordero E, Perez-Ordoñez A, Aydillo TA, Torre-Cisneros J, Gavalda J, Lara R, Segura C, Len O, Cabral E, Gasch A, Pachon J, Perez-Romero P.
Therapy With m-TOR Inhibitors Decreases the Response to the Pandemic Influenza A H1N1 Vaccine in Solid Organ Transplant Recipients.
AMERICAN JOURNAL OF TRANSPLANTATION 2011; 11: 2205-13.


Doblas A, Torre-Cisneros J.
The current state of tuberculosis in solid organ transplantation: three principles for optimal management.
AMERICAN JOURNAL OF TRANSPLANTATION 2011; 11: 1769-70.


Eworo A, Muñoz P, Yáñez JF, Palomo J, Guembe P, Roda J, Valerio M, Guinea J, Bouza E.
Cardiac invasive aspergillosis in a heart transplant recipient.
REVISTA IBEROAMERICANA MICOLOGIA 2011; 28:134-8.


Fariñas MC, Torre-Cisneros J, Pahissa A.
Luces y sombras de la infección por citomegalovirus en el trasplante de órgano sólido.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6):1-3.


Fortún J, Carratalà J, Gavaldà J, Lizasoain M, Salavert M, de la Cámara R, Borges M, Cervera C, Garnacho J, Lassaleta A, Lumbreras C, Sanz MA, Ramos JT, Torre-Cisneros J, Cuenca-Estrella M, Aguado JM y Grupo de Estudio de Micología Médica de la SEIMC.
Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2011; 29: 435-454.


Fortún J, Sanz MA, Madero L, López J, de la Torre J, Jarque I, Vallejo C.
Update on bacteraemia in oncology and hematology.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 4): 48-53.


Garcia-Reyne A, López-Medrano F, Morales JM, García Esteban C, Martín I, Eraña I, Meije Y, Lalueza A, Alastruey-Izquierdo A, Rodríguez-Tudela JL, Aguado JM.
Cutaneous infection by Phomopsis longicolla in a renal transplant recipient from Guinea: first report of human infection by this fungus.
TRANSPLANT INFECTIOUS DISEASE 2011;13(2):204-7


Garcia-Vidal C, Barba P, Arnan M, Moreno A, Ruiz-Camps I, Gudiol C, Ayats J, Ortí G, Carratalà J.
Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients.
CLINICAL INFECTIOUS DISEASES 2011; 53: e16-19.


Gavaldà J, Monforte V, Len O.
Prevención de la enfermedad por citomegalovirus en el trasplante de pulmón.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 46-51.


Gracia-Ahufinger I, Torre-Cisneros J.
La infección por citomegalovirus en el trasplante renal: de las lecciones aprendidas a los retos de futuro.
MEDICINA CLÍNICA (Barc) 2011; 137: 349-351.


Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega L, Duarte R, Calvo M, Carratalà J.
Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2011; 66: 657-663.


Gurgui M, Sanchez F, March F, Lopez-Contreras J, Martino R, Cotura A, Galvez ML, Roig C, Coll P.
Nosocomial outbreak of Blastoschizomyces capitatus associated with contaminated milk in a haematological unit.
JOURNAL OF HOSPITAL INFECTION 2011; 78: 274-8.


Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, Ison M, Humar A, Padera RF, Lawler LP, Fisher A, Drew RJ, Gould KF, Sole A, Studer S, Munoz P, Singer LG, Hannan M.
ISHLT Infectious Diseases Council Working Group on Definitions. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients.
JOURNAL HEART LUNG TRANSPLANTATION 2011; 30: 361-74.


Lázaro M, Ramos A, Ussetti P, Asensio A, Laporta R, Muñez E, Sánchez-Romero I, Tejerina E, Burgos R, Moñivas V, Varela A.
Aspergillus endocarditis in lung transplant recipients: case report and literature review.
TRANSPLANT INFECTIOUS DISEASES. 2011; 13: 186-91.


Linares L, Sanclemente G, Cervera C, Hoyo I, Cofán F, Ricart MJ, Pérez-Villa F, Navasa M, Marcos MA, Antón A, Pumarola T, Moreno A.
Influence of cytomegalovirus disease in outcome of solid organ transplant patients.
TRANSPLANTATION PROCEEDINGS 2011; 43: 2145-8.


Loeches B, Valerio M, Palomo J, Bouza E, Muñoz P.
BK virus in heart transplant recipients: A prospective study.
JOURNAL HEART LUNG TRANSPLANTATION 2011; 30: 109-11.


López-Medrano F, Fernández-Ruiz M, Morales JM, Cervera C, Ramos A, Carratalà J, Torre-Cisneros J, San Juan R, Gavaldà J, Muñoz P, Pahissa A, Martín-Dávila P, Montejo M, Lumbreras C, Moreno A, Amado A, Aguado JM.
Impact of hepatitis C virus on the development of infectious complications after kidney transplantation. Results from the RESITRA/REIPI cohort.
TRANSPLANTATION 2011; 92: 543-549.


Marcos MA.
Estudio de resistencia. ¿Cuándo están indicados?
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 24-27.


Martín-Dávila P, Fortún J, San Juan R.
Profilaxis de la infección por citomegalovirus en el trasplante intestinal.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 60-64.


Martín-Peña A, Aguilar-Guisado M, Espigado I, Parody R, Cisneros JM.
Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients.
CLINICAL TRANSPLANTATION 2011: 25: 468–474.


Martina MN, Cofan F, Suarez A, Masso E, Trullas JC, Cervera C, Moreno A, Oppenheimer F, Miiro JM, Campistol JM.
Kidney transplantation and waiting list for renal transplantation for human immunodeficiency virus patients.
TRANSPLANTATION PROCEEDINGS 2011; 43: 2179-81.


Martínez-Bravo MJ, Tallón I, Espigado I, Perez-Simón JA, Pérez-Romero P, Gracia-Ahufinger I, Aguilera I, Núñez-Roldán A.
Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease.
IMMUNOLOGY LETTER 2011; 30; 141:140-4.


Meije Y, Aguado JM, Cuenca-Estrella M.
Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implications.
BONE MARROW TRANSPLANTATION 2011;46(7):1016-7


Montejo M.
Definiciones y conceptos de interés en la infección por citomegalovirus: infección frente a enfermedad. Replicación, carga viral, profilaxis universal. Terapia anticipada.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 4-5.


Montejo M.
Epidemiología de la infección fúngica invasora en el trasplante de órgano sólido.
REVISTA IBEROAMERICANA MICOLOGÍA 2011; 28: 120-123.


Moreno A, Cervera C, Fortún J, Blanes M, Montejo M, Abradelo M, Len O, Rafecas, A, Martín-Dávila P, Torre-Cisneros J, Salcedo M, Cordero E, Lozano R, Pérez I, Rimola A, Miró JM and the OLT-HIV FIPSE Cohort Investigators.
Epidemiology and Outcome of Infections in HIV/HCV-Coinfected Liver Transplant Recipients: A FIPSE/GESIDA Prospective Cohort Study.
LIVERS TRANSPLANTATION 2011; 18: 70-81.


Moreno A, Fortún J, Graus J, Rodriguez-Gandía MA, Quereda C, Pérez-Elías MJ, Nuño J, Wikman P, Moreno S, Bárcena R.
Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia.
LIVER TRANSPLANTATION 2011; 17: 331-3.


Moreno A, Rodríguez A.
Profilaxis de la infección por citomegalovirus en el trasplante de páncreas.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 56-59.


Muñoz P, Crespo MG.
Profilaxis de la infección por citomegalovirus en el trasplante de corazón.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 52-55.


Muñoz P, Valerio M, Eworo A, Bouza E.
Parasitic infections in solid-organ transplant recipients.
CURRENT OPINION IN ORGAN TRANSPLANTATION 2011; 16: 565-575.


Pemán J, Torre-Cisneros J.
Micafungina: nuevos retos, nuevas posibilidades en el tratamiento de la infección fúngica invasora.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 1): 1-2.


Pérez J, Grande LG, Achécar L, Moreno A, Fortún J, Arranz G, Tejedor M, Blázquez J, Sánchez J, Moreno A, Pian H, Bárcena R.
Case report of splenic artery steal syndrome: demonstration of portal hyperflow mechanism by anatomic variant of the splenic artery and correlation with Doppler rates.
TRANSPLANTATION PROCEEDINGS 2011; 43: 2269-71.


Pérez JL.
Técnicas de monitorización de la infección por citomegalovirus en los trasplantados de órgano sólido.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 4-5.


Pérez JL, Ayats J, Fortún J, de Oña M, Pumarola T.
Microbiology of transplants.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29: 683-90.


Quindós M, Montejo M.
Enfermedades fúngicas invasoras en receptores de trasplante de órgano sólido.
REVISTA IBEROAMERICANA MICOLOGÍA 2011; 28: 109.


Rodríguez-Hernández MJ, Ruiz-Pérez de Pipaon M, Márquez-Solero M, Martín-Rico P, Castón-Osorio JJ, Guerrero-Sánchez FM, Vidal-Verdú E, García-Figueras C, Del Arco-Jiménez A, Rodríguez-Baño J, Martín-Mazuelos E, Cisneros-Herreros JM; por el Grupo de Investigadores de la Sociedad Andaluza de Microbiología y Parasitología (SAMPAC) y de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).
Candidemias: análisis multicéntrico en 16 hospitales andaluces.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29: 328-33.


Ruiz-Camps I, Aguado JM, Almirante B, Bouza E, Ferrer-Barbera CF, Len O, Lopez-Cerero L, Rodríguez-Tudela JL, Ruiz M, Solé A, Vallejo C, Vazquez L, Zaragoza R, Cuenca-Estrella M; GEMICOMED (Medical Mycology Study Group of SEIMC).
Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).
CLINICAL MICROBIOLOGY AND INFECTION 2011; 17 (Suppl. 2): 1–24


Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI).
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
ANTIVIRAL THREAPY 2011; 16:951-7.


Salvador F, Len O, Molina I, Sulleiro E, Sauleda S, Bilbao I, Castells L, Pont T, Gavaldà J, Pahissa A.
Safety of liver transplantation performed with Chagas seropositive donors to seronegative recipients.
LIVER TRANSPLANTATION 2011; 17: 1304-8.


San Juan R, Aguado JM, Lumbreras C, Fortún J, Len O, Muñoz P, Montejo M, Moreno A, Cordero E, Blanes M, Ramos A, Torre-Cisneros J, López-Medrano F, Carratalà J, Moreno E.
Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infection after liver transplantation.
LIVER TRANSPLANTATION 2011; 17: 896-904.


San Juan R, Aguado JM, Lumbreras C, Fortún J, Len O, Muñoz P, Montejo M, Moreno A, Cordero E, Blanes M, Ramos A, Torre-Cisneros J, López-Medrano F, Carratalà J, Moreno E.
Universal prophylaxis with fluconazole for the prevention of early invasive infection in low risk liver transplant recipients.
TRANSPLANTATION 2011; 92: 346-350.


Sánchez Fructuoso AI, Calvo N, Perez-Flores I, Valero R, Rodríguez-Sánchez B, García de Viedma D, Muñoz P, Barrientos A.
Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients.
TRANSPLANT INFECTIOUS DISEASES 2011; 13: 584-591.


Santos F, Carratalà J.
Tratamiento de la enfermedad por citomegalovirus.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA 2011; 29 (Supl 6): 65-69.


Torre-Cisneros J, Fariñas MC, Castón JJ, Aguado JM, Cantisán S, Carratalà J, Cervera C, Cisneros JM, Cordero E, Crespo-Leiro MG, Fortún J, Frauca E, Gavaldà J, Gil-Vernet S, Gurguí M, Len O, Lumbreras C, Marcos MA, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pahissa A, Pérez JL, Rodríguez-Bernot A, Rumbao J, San-Juan R, Santos F, Varo E, Zurbano F.
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA 2011; 29: 735-758.


Viasus D, Gudiol C, Fernández-Sabé N, Cabello I, Garcia-Vidal C, Cisnal M, Duarte R, Antonio M, Carratalà J.
Effect of statins on outcomes in immunosuppressed patients with bloodstream infection.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES 2011; 30: 77-82.

 
Documentos Consenso

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations


Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)


Executive summary. Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)


Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).


GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.


Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).


Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).


Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).


Consensus document for the management of tuberculosis in solid organ transplant recipients.


Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.

 



     ponencias


ASTELLAS GILEAD MSD PFIZER

225894 visitas
zona privada